Navigation Links
Portrait(R) Plasma Receives Clearance from the FDA to Treat Acne Scars
Date:4/2/2008

WALTHAM, Mass., April 2, 2008 /PRNewswire/ -- Rhytec, Inc. the pioneer of plasma skin regeneration and sole provider of an aesthetic device which uses a novel thermal energy called plasma for reversing the signs of aging, today announced it has received U.S. Food and Drug Administration (FDA) clearance to market a new indication for treating acne scars. Portrait(R) Plasma is already cleared by the FDA for treating facial and non-facial areas for wrinkles, superficial skin lesions, actinic keratosis, seborrhoeic keratosis and viral papillomata.

An initial single site clinical study treating acne scars was conducted using the Portrait PSR3 plasma system. M. Potter, et al, evaluated 9 patients after one Portrait Plasma treatment and found acne scarring improved by 23% at six months and sustained for two years. Although this sample size was limited, an objective evaluation method was used as compared to the subjective methods (visual observation) used in most other studies. Silicone elastomer molds were made of the skin irregularities before and after treatment and compared by measuring the depth of the defects. A 35% decrease in acne scar depth was found in this elastomer evaluation (Potter et al. Annals of Plastic Surgery. Volume 58, Number 6, June 2007).

Rhytec then conducted a multi-center IRB clinical study at three sites evaluating Portrait Plasma treatment of areas of sunken, atrophic, post acne scars (G. Lask/P. Yamauchi, J.F. Tremblay & N. Uebelhoer). Twenty-nine patients completed the one treatment protocol with physicians reporting a mean improvement of 29% in acne scar appearance at 6 months. Patient self assessment was 35% average improvement and seventy-one percent (71%) of patients would recommend the procedure to a friend. These results were obtained after a single Portrait(R) Plasma treatment compared to the six treatments patients endure with the 1320 nm Nd:Yag and up to 5 treatments with fractional lasers.

Portrait Plasma is a one of its kind - novel, non-invasive, in-office technology clinically proven to treat unhealthy signs of aging often accelerated by sun exposure and acne scars. Plasma treats 100% of the skin; it stimulates a natural response producing healthier regeneration of the skin. Different from lasers which only target specific components of the skin, physicians and patients feel that with plasma's unique approach results are maximized. This is especially important when treating acne scars, all wrinkles, skin laxity and pre-cancerous lesions, such as actinic keratosis. Further, unlike other procedures on the market, like CO2, erbium, or fractionated lasers, Portrait Plasma offers less downtime and little to no risk of hypopigmentation, scarring or discoloration as seen in this clinical study.

About Portrait Plasma:

Portrait(R) PSR3 harnesses the power of plasma to deliver dramatic skincare results without the risk or down time associated with laser procedures. The hand-piece delivers nitrogen plasma energy that works both at and below the surface of the skin to modify its architecture and generate new collagen for up to two years. Portrait Plasma has been proven to treat fine lines and deep wrinkles, sun damage, pre-cancerous lesions, dyschromia and tighten skin. It also improves pore size, elasticity, and tone and texture of the face and body.

About Rhytec - The Makers of Portrait Plasma:

Rhytec develops innovative plasma technologies based on sound scientific and clinical research for the dermatological, plastic and cosmetic surgery markets. Plasma energy stimulates a true, natural skin regenerative process that is supported by over 30 completed and ongoing clinical trials. Founded in 2004, Rhytec works with leading dermatologists, plastic surgeons, and cosmetic physicians to develop new technologies that enhance the skin's appearance and function, improving the quality of life for patients seeking treatment. Rhytec, Inc. is privately held, based in Waltham, MA (US), and is a subsidiary of Rhytec, Ltd. in Berkshire (UK).


'/>"/>
SOURCE Rhytec, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
2. Toxoplasma infection increases risk of schizophrenia, study suggests
3. Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program
4. Test gives insight into prognosis in patients with plasma cell malignancies, finds Mayo Clinic study
5. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
6. New Studies Find Plasma Disc Decompression Effective for Contained Disc Herniation
7. CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders Equity
8. Western Reserve Heart Care Receives ICANL Nuclear Medicine Accreditation
9. AIDS Activist Gregg Gonsalves Receives $100,000 Leadership Award
10. Emageon Receives Best in KLAS Cardiology PACS Award
11. London Luxury Receives Asthma & Allergy Friendly(TM) Certification for Several of Its Bedding Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... , ... Mediaplanet is proud to announce the launch of ... treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage ... in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This ...
(Date:12/2/2016)... ... , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology ... health technology on the market can deliver all that rejiva can. , “Rejiva promotes ... their health than the usual heart rate and steps taken”, adds Evens Augustin, CEO ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today ... intelligent, connected applications, was named the best Sales Team of 2016 as part ... was made today by the Software & Information Industry Association (SIIA), the principal ...
(Date:11/30/2016)... ... , ... "I hate when the mixture of saliva and toothpaste runs down ... from Bridgewater, N.J. "I thought that there had to be a way to prevent ... patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle onto ...
(Date:11/30/2016)... U.K. (PRWEB) , ... November 30, 2016 , ... ... address the tech functions and stylish design wanted by today’s consumers at an ... Cronovo Co-Founder Darin Philip says the new watch is “a game changer” when ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... WOONSOCKET, R.I. , Dec. 2, 2016 ... hold its annual Analyst Day in New York City on Thursday, December ... the CVS Health leadership team will provide an in-depth ... and enhance shareholder value. The company will also discuss ... audio and video webcast of the event will be ...
(Date:12/2/2016)... 2, 2016 Orthopedic Implants (Including Spinal ... Expected to Gain a Significant Market Share Owing to a ... ... According to a new report by ... Sterile Packaging: Clamshell Product Type Segment Projected to Witness a ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology: